| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES INC | Director | Common Stock | 33.1K | $2.84M | $85.78 | May 6, 2021 | Direct |
| GILEAD SCIENCES INC | Director | Restricted Stock Unit | 4.03K | $318K | $79.02 | May 6, 2021 | Direct |
| Virios Therapeutics, Inc. | Director | Stock Option (right to buy) | 4K | Feb 26, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VIRI | Virios Therapeutics, Inc. | Feb 26, 2024 | 1 | $0 | 4 | Feb 28, 2024 | Director |
| VIRI | Virios Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| VIRI | Virios Therapeutics, Inc. | Dec 8, 2022 | 1 | -$466 | 4 | Dec 12, 2022 | Director |
| VIRI | Virios Therapeutics, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 30, 2022 | Director |
| VIRI | Virios Therapeutics, Inc. | May 18, 2022 | 1 | $2.26K | 4 | May 19, 2022 | Director |
| VIRI | Virios Therapeutics, Inc. | Jan 6, 2022 | 1 | $10.3K | 4 | Jan 7, 2022 | Director |
| VIRI | Virios Therapeutics, Inc. | Dec 23, 2021 | 1 | $1.15K | 4 | Dec 23, 2021 | Director |
| VIRI | Virios Therapeutics, Inc. | Jun 22, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Director |
| GILD | GILEAD SCIENCES INC | May 6, 2021 | 2 | $0 | 4 | May 7, 2021 | Director |